High energy, double pass helium plasma dermal resurfacing: A prospective, multicenter, single-arm clinical study.

ABSTRACT:

Background

A previous multi-center clinical study of low energy (20% power), single-pass helium plasma dermal resurfacing (HPDR) showed positive results but did not fully reveal the true potential of this novel technology. A second multi-center clinical study, reported herein, was therefore undertaken to evaluate efficacy and safety of high energy (40%), double pass HPDR for treatment of facial rhytids (ClinicalTrials.gov Identifier: NCT04185909).

Methods

Fifty-five eligible subjects seeking improvement in facial rhytids were enrolled for study at one of four investigational sites. All subjects underwent full-face HPDR treatment. The forehead, nose, cheeks, and peri-oral treatment zones were treated at 40% power with two passes whereas the peri-orbital and jawline/mandibular

SUBMITTER: Holcomb JD 

PROVIDER: S-EPMC9305223 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature